UP!
| Period | Date | Adjusted Actuals EPS | GAAP EPS |
|---|---|---|---|
| Q4 2022 | 2023-02-07 | Future report Set alerts | |
| Q3 2022 | 2022-11-01 | 0.60 | 0.60 |
| Q2 2022 | 2022-08-02 | 1.01 | 1.01 |
| Q1 2022 | 2022-05-03 | 0.55 | 0.55 |
| Q4 2021 | 2022-02-08 | 0.10 | 0.10 |
| Q3 2021 | 2021-11-02 | 1.18 | 1.18 |
| Q2 2021 | 2021-08-03 | 0.80 | 0.80 |
| Q1 2021 | 2021-05-04 | 0.67 | 0.67 |
| Q4 2020 | 2021-02-09 | 0.93 | 0.93 |
| Q3 2020 | 2020-11-05 | 0.23 | 0.23 |
| 2016-06-29 | Reiterated Rating | Goldman Sachs Group Inc. | Buy | |
| 2016-06-15 | Reiterated Rating | JMP Securities | Outperform | $100.00 |
| 2016-06-07 | Reiterated Rating | BMO Capital Markets | Buy | $91.00 to $97.00 |
| 2016-06-06 | Reiterated Rating | Brean Capital | Buy | |
| 2016-05-19 | Reiterated Rating | Morgan Stanley | Buy | |
| 2016-05-10 | Reiterated Rating | Jefferies Group | Buy | $88.00 |
| 2016-05-10 | Reiterated Rating | Oppenheimer | Buy | |
| 2016-05-10 | Reiterated Rating | Morgan Stanley | Buy | |
| 2016-05-10 | Reiterated Rating | Brean Capital | Buy | $92.00 |
| 2016-05-10 | Reiterated Rating | Oppenheimer Holdings Inc. | Buy | |
| 2016-05-03 | Reiterated Rating | Cowen and Company | Buy | |
| 2016-05-02 | Reiterated Rating | Oppenheimer | Buy | |
| 2016-04-18 | Reiterated Rating | Oppenheimer | Buy | |
| 2016-04-18 | Reiterated Rating | Leerink Swann | Buy | |
| 2016-04-17 | Reiterated Rating | Cowen and Company | Buy | |
| 2016-04-13 | Reiterated Rating | Jefferies Group | Buy | $88.00 |
| 2016-04-07 | Initiated Coverage | BMO Capital Markets | Outperform | $92.00 |
| 2016-04-06 | Lower Price Target | Jefferies Group | Buy | $88.00 |
| 2016-04-06 | Reiterated Rating | Leerink Swann | Buy | |
| 2016-04-06 | Reiterated Rating | Cowen and Company | Buy | |
| 2016-03-31 | Reiterated Rating | Leerink Swann | Buy | |
| 2016-03-30 | Lower Price Target | Leerink Swann | Outperform | $94.00 to $85.00 |
| 2016-03-23 | Initiated Coverage | Morgan Stanley | Overweight | $85.00 |
| 2016-03-07 | Reiterated Rating | Cowen and Company | Buy | |
| 2016-02-22 | Boost Price Target | Argus | Buy | $92.00 to $135.00 |
| 2016-02-16 | Reiterated Rating | Leerink Swann | Outperform | $118.00 to $94.00 |
| 2016-02-13 | Reiterated Rating | Oppenheimer | Buy | |
| 2016-02-12 | Lower Price Target | Oppenheimer | Outperform | $129.00 to $108.00 |
| 2016-02-12 | Reiterated Rating | Brean Capital | Buy | $131.00 to $92.00 |
| 2016-02-12 | Boost Price Target | Barclays | Overweight | $25.00 to $85.00 |
| 2016-02-12 | Boost Price Target | Barclays PLC | Overweight | $25.00 to $85.00 |
| 2016-02-11 | Boost Price Target | Piper Jaffray | Overweight | $65.00 to $125.00 |
| 2016-02-11 | Boost Price Target | Piper Jaffray Cos. | Overweight | $65.00 to $125.00 |
| 2016-02-08 | Reiterated Rating | Leerink Swann | Outperform | $118.00 |
| 2016-01-31 | Reiterated Rating | Bank of America | Buy | $145.00 to $87.00 |
| 2016-01-31 | Reiterated Rating | Bank of America Corp. | Buy | $145.00 to $87.00 |
| 2016-01-30 | Reiterated Rating | Oppenheimer | Outperform | $129.00 |
| 2016-01-28 | Reiterated Rating | JPMorgan Chase & Co. | Buy | |
| 2016-01-19 | Initiated Coverage | Credit Suisse | Outperform | $110.00 |
| 2016-01-19 | Initiated Coverage | Credit Suisse Group AG | Outperform | $110.00 |
| 2016-01-13 | Reiterated Rating | Oppenheimer | Outperform | $129.00 |
| 2016-01-07 | Reiterated Rating | Piper Jaffray | Overweight | |
| 2016-01-05 | Initiated Coverage | Raymond James | Market Perform | |
| 2016-01-05 | Initiated Coverage | Raymond James Financial Inc. | Market Perform | |
| 2015-11-19 | Reiterated Rating | UBS AG | Buy | $130.00 |
| 2015-11-18 | Initiated Coverage | Goldman Sachs | Buy | $135.00 |
| 2015-11-12 | Boost Price Target | Leerink Swann | Outperform | $130.00 to $135.00 |
| 2015-11-11 | Reiterated Rating | Piper Jaffray | Overweight | $135.00 |
| 2015-11-09 | Boost Price Target | Oppenheimer | Outperform | $121.00 to $129.00 |
| 2015-11-04 | Boost Price Target | JMP Securities | Market Outperform | $127.00 to $133.00 |
| 2015-11-04 | Boost Price Target | Jefferies Group | Buy | $135.00 to $142.00 |
| 2015-11-04 | Boost Price Target | Brean Capital | $119.00 to $131.00 | |
| 2015-11-03 | Reiterated Rating | Piper Jaffray | Buy | |
| 2015-10-18 | Reiterated Rating | Piper Jaffray | Buy | |
| 2015-10-15 | Reiterated Rating | Jefferies Group | Buy | $140.00 to $135.00 |
| 2015-10-15 | Reiterated Rating | JPMorgan Chase & Co. | Overweight | $118.00 |
| 2015-10-06 | Boost Price Target | Nomura | Buy | $126.00 to $146.00 |
| 2015-10-06 | Boost Price Target | Nomura Holdings Inc. | Buy | $126.00 to $146.00 |
| 2015-09-30 | Reiterated Rating | Leerink Swann | Outperform | |
| 2015-09-16 | Reiterated Rating | Cowen and Company | Buy | |
| 2015-09-08 | Initiated Coverage | Jefferies Group | Buy | $140.00 |
| 2015-09-03 | Reiterated Rating | JPMorgan Chase & Co. | Overweight | $118.00 |
| 2015-09-02 | Reiterated Rating | Brean Capital | Buy | |
| 2015-08-18 | Reiterated Rating | Piper Jaffray | Overweight | $130.00 |
| 2015-08-18 | Boost Price Target | Argus | Buy | $125.00 to $135.00 |
| 2015-08-17 | Reiterated Rating | Cowen and Company | Outperform | |
| 2015-08-13 | Initiated Coverage | Barclays | Overweight to Overweight | $125.00 |
| 2015-08-05 | Boost Price Target | JMP Securities | Market Outperform | $125.00 to $127.00 |
| 2015-08-05 | Reiterated Rating | Brean Capital | Buy | $107.00 to $119.00 |
| 2015-08-04 | Reiterated Rating | JPMorgan Chase & Co. | Buy | $111.00 to $118.00 |
| 2015-07-25 | Reiterated Rating | Piper Jaffray | Buy | $121.00 to $130.00 |
| 2015-07-22 | Reiterated Rating | Cowen and Company | Outperform | |
| 2015-06-25 | Reiterated Rating | Cowen and Company | Buy | |
| 2015-06-17 | Reiterated Rating | Oppenheimer | Outperform | $121.00 |
| 2015-06-11 | Reiterated Rating | Cowen and Company | Buy | |
| 2015-05-29 | Initiated Coverage | Bank of America | Buy | $126.00 |
| 2015-05-24 | Reiterated Rating | JPMorgan Chase & Co. | Overweight | $111.00 |
| 2015-05-09 | Reiterated Rating | Oppenheimer | Outperform | $89.00 to $121.00 |
| 2015-05-06 | Boost Price Target | Argus | Buy | $92.00 to $125.00 |
| 2015-05-01 | Reiterated Rating | Piper Jaffray | Overweight | $121.00 |
| 2015-04-30 | Boost Price Target | Brean Capital | Buy | $84.00 to $107.00 |
| 2015-04-21 | Boost Price Target | Piper Jaffray | Overweight | $80.00 to $121.00 |
| 2015-04-20 | Boost Price Target | SunTrust | Buy | $93.00 to $120.00 |
| 2015-04-20 | Boost Price Target | SunTrust Banks Inc. | Buy | $93.00 to $120.00 |
| 2015-04-15 | Boost Price Target | JMP Securities | Market Outperform | $97.00 to $105.00 |
| 2015-02-23 | Boost Price Target | Oppenheimer | Outperform | $75.00 to $89.00 |
| 2015-02-18 | Boost Price Target | Argus | Buy | $85.00 to $92.00 |
| 2015-02-17 | Boost Price Target | Leerink Swann | Outperform | $80.00 to $90.00 |
| 2015-02-13 | Boost Price Target | JMP Securities | Market Outperform | $86.00 to $97.00 |
| 2015-02-12 | Boost Price Target | Brean Capital | Buy | $76.00 to $84.00 |
| 2015-01-27 | Reiterated Rating | Bank of America | Buy | $85.00 to $92.00 |
| 2014-10-30 | Upgrade | Goldman Sachs | Sell to Neutral | $32.00 to $62.00 |
| 2014-10-30 | Boost Price Target | Brean Capital | Buy | $74.00 to $76.00 |
| 2014-09-17 | Reiterated Rating | Argus | Buy | $85.00 to $50.00 |
| 2014-09-04 | Initiated Coverage | SunTrust | Buy | $71.00 |
| 2014-07-24 | Reiterated Rating | Nomura | Buy | $90.00 |
| 2014-06-02 | Reiterated Rating | Nomura | Buy | $90.00 |
| 2014-05-15 | Reiterated Rating | Morgan Stanley | Underweight | $14.00 |
| 2014-05-02 | Lower Price Target | Nomura | Buy | $93.00 to $90.00 |
| 2014-04-29 | Initiated Coverage | Leerink Swann | Outperform | $76.00 |
| 2014-03-17 | Boost Price Target | Argus | Buy | $65.00 to $85.00 |
| 2014-02-26 | Initiated Coverage | Bank of America | Buy | $84.00 |
| 2014-02-13 | Boost Price Target | Barclays | Overweight | $64.00 to $75.00 |
| 2014-02-13 | Boost Price Target | Canaccord Genuity | Buy | $79.00 to $85.00 |
| 2014-01-21 | Boost Price Target | Nomura | $83.00 | |
| 2014-01-16 | Boost Price Target | Canaccord Genuity | Buy | $65.00 to $79.00 |
| 2014-01-14 | Boost Price Target | Brean Capital | Buy | $52.00 to $66.00 |
| 2014-01-10 | Set Price Target | Jefferies Group | $44.00 to $75.00 | |
| 2014-01-10 | Upgrade | Barclays | Equal Weight to Overweight | $36.00 to $64.00 |
| 2014-01-08 | Initiated Coverage | Nomura | Buy | $68.00 |
| 2014-01-06 | Boost Price Target | Canaccord Genuity | Buy | $55.00 to $65.00 |
| 2013-12-10 | Boost Price Target | Canaccord Genuity | Buy | $47.00 to $55.00 |
| 2013-11-29 | Boost Price Target | Argus | Buy | $45.00 to $65.00 |
| 2013-11-26 | Initiated Coverage | Piper Jaffray | Overweight | $56.00 |
| 2013-11-15 | Boost Price Target | Brean Capital | Buy | $45.00 to $52.00 |
| 2013-11-01 | Boost Price Target | Guggenheim | Buy | $47.00 to $50.00 |
| 2013-11-01 | Boost Price Target | Cowen and Company | Outperform | $39.00 to $45.00 |
| 2013-11-01 | Boost Price Target | Canaccord Genuity | Buy | $38.00 to $47.00 |
| 2013-10-02 | Reiterated Rating | Brean Capital | Buy | $45.00 |
| 2013-09-23 | Reiterated Rating | Jefferies Group | Buy | |
| 2013-09-20 | Reiterated Rating | Oppenheimer | Buy | $43.00 |
| 2013-09-20 | Boost Price Target | Barclays | Equal Weight | $22.00 to $36.00 |
| 2016-06-29 | Reiterated Rating | Goldman Sachs Group Inc. | Buy | |
| 2016-06-15 | Reiterated Rating | JMP Securities | Outperform | $100.00 |
| 2016-06-07 | Reiterated Rating | BMO Capital Markets | Buy | $91.00 to $97.00 |
| 2016-06-06 | Reiterated Rating | Brean Capital | Buy | |
| 2016-05-19 | Reiterated Rating | Morgan Stanley | Buy |
There is presents forecasts of rating agencies and recommendations for investors about this ticker
In INCY 391 funds of 2213 total. Show all
| Fund name | Ticker shares |
|---|---|
| BAKER BROS. ADVISORS LP | 36.15M |
| Vanguard Group, Inc | 21.23M |
| DODGE & COX | 19.79M |
| BlackRock Inc. | 19.64M |
| WELLINGTON MANAGEMENT CO LLP | 10.32M |
| STATE STREET CORP | 9.55M |
| ROYAL BANK OF CANADA | 9.21M |
| RENAISSANCE TECHNOLOGIES LLC | 4.85M |
| BlackRock Fund Advisors | 4.44M |
| BlackRock Institutional Trust Company, N.A. | 4.44M |
| GEODE CAPITAL MANAGEMENT, LLC | 3.77M |
| ARMISTICE CAPITAL, LLC | 2.37M |
| Invesco Ltd. | 2.36M |
| PRICE T ROWE ASSOCIATES INC /MD/ | 2.31M |
| NORTHERN TRUST CORP | 1.93M |
| Name Relationship | Total Shares | Holding stocks |
|---|---|---|
| BAKER BROS. ADVISORS LP | 0.47% (790006) | ACAD / AQXP / BCRX / GHDX / IDRA / INCY / MRTX / SGEN / XOMA / |
| BAKER JULIAN | 0.46% (767095) | GEVA / IDRA / INCY / |
| WHITFIELD ROY A | 0.40% (666082) | ILMN / INCY / NKTR / |
| Hoppenot Herve President and CEO | 0.16% (276690) | INCY / |
| FRIEDMAN PAUL A Chief Executive Officer | 0.16% (269011) | AUXL / CERU / DRTX / INCY / SNTA / VSTM / |
| BROOKE PAUL A | 0.13% (217859) | INCY / VPHM / |
| DE SCHUTTER RICHARD U Chairman | 0.05% (92290) | DRTX / INCY / VRX / |
| ARIKO BARRY A | 0.03% (45834) | INCY / |
| Wenqing Yao EVP, Discovery Medicinal and P | 0.02% (35584) | INCY / |
| Huber Reid M EVP, Chief Scientific Officer | 0.02% (35183) | INCY / |
| SWAIN PAULA J EVP, Human Resources | 0.02% (33367) | INCY / |
| Siegel Eric H. EVP, General Counsel | 0.01% (21053) | INCY / |
| Levy Richard S EVP, Chief Drug Dev&Medical Of | 0.01% (16926) | INCY / SNTA / |
| Stein Steven H EVP & Chief Medical Officer | 0.01% (15459) | INCY / |
| Flannelly Barry P See Remarks | 0.01% (13823) | INCY / |
| Iyengar Vijay K EVP GPS, BD, & Licensing | 0.01% (13676) | INCY / |
| Trower Paul Principal Accounting Officer | 0.01% (11439) | INCY / |
| GRYSKA DAVID W Executive Vice President, CFO | 0.01% (10970) | AERI / HPTX / INCY / PDLI / SGEN / |
| DIXON WENDY L | 0.01% (9467) | ALKS / BLUE / EBIO / FURX / INCY / OREX / |
| HASTINGS DAVID C Chief Financial Officer | 0.01% (8500) | INCY / SCYX / UNIS / |
UM